InspireMD (NSPR) Gross Profit Growth (1y) (2011 - 2025)
InspireMD (NSPR) Gross Profit Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.74% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 27.39% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -1.74% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 6.30% |
| 10 | InspireMD | 43.74 Mn | -10.47 Mn | 1.18 Mn | 151.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 151.60% |
| Sep 30, 2025 | 108.70% |
| Jun 30, 2025 | -5.44% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -7.13% |
| Sep 30, 2024 | -5.48% |
| Jun 30, 2024 | -32.59% |
| Mar 31, 2024 | -21.72% |
| Dec 31, 2023 | 155.05% |
| Sep 30, 2023 | 19.67% |
| Jun 30, 2023 | 13.92% |
| Mar 31, 2023 | 205.74% |
| Dec 31, 2022 | -32.65% |
| Sep 30, 2022 | 297.83% |
| Jun 30, 2022 | 64.50% |
| Mar 31, 2022 | 15.09% |
| Dec 31, 2021 | 175.38% |
| Sep 30, 2021 | -69.13% |
| Jun 30, 2021 | 318.33% |
| Mar 31, 2021 | -64.07% |